ForDoz Pharma Corporation

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Biotechnology
  • Contract Research Organization-CRO
  • Contract Manufacturing Organization
See more in Biomedtracker

Latest on ForDoz Pharma Corporation

Generics Bulletin

Lupin Expects Respiratory Ramp Up From Fiscal '22

 
• By Vibha Ravi

Lupin expects its respiratory portfolio to begin delivering growth from fiscal 2022 which starts this 1 April, although sales in the third quarter of its current financial year fell behind expectatio

Scrip

Lupin Expects Respiratory Ramp Up From Fiscal '22

 
• By Vibha Ravi

Lupin Limited expects its respiratory portfolio to begin delivering growth from fiscal 2022 which starts this 1 April, although sales in the third quarter of its current financial year fell behind ex

Scrip

Deal Watch: NewAmsterdam To Take On Amgen’s Stalled CETP Inhibitor

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. NewAmsterdam’s Plans For Obicetrapib In